カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の慢性疲労症候群治療薬市場予測2023-2029：鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬

【英語タイトル】Chronic Fatigue Syndrome Therapeutics Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8416）・商品コード：MMG23LY8416
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：61
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の慢性疲労症候群治療薬市場規模と予測を収録しています。・世界の慢性疲労症候群治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の慢性疲労症候群治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の慢性疲労症候群治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「鎮痛剤・NSAID」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

慢性疲労症候群治療薬のグローバル主要企業は、AIM ImmunoTech、 Apotex、 Aurobindo Pharma、 Bionpharma、 Cadila Pharmaceuticals、 Hikma Pharmaceuticals、 Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceutical Industries、 Viatrisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、慢性疲労症候群治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の慢性疲労症候群治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の慢性疲労症候群治療薬市場：タイプ別市場シェア、2022年
・鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬

世界の慢性疲労症候群治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の慢性疲労症候群治療薬市場：用途別市場シェア、2022年
・総合病院、専門医院

世界の慢性疲労症候群治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の慢性疲労症候群治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における慢性疲労症候群治療薬のグローバル売上、2018年-2023年
・主要企業における慢性疲労症候群治療薬のグローバル売上シェア、2022年
・主要企業における慢性疲労症候群治療薬のグローバル販売量、2018年-2023年
・主要企業における慢性疲労症候群治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AIM ImmunoTech、 Apotex、 Aurobindo Pharma、 Bionpharma、 Cadila Pharmaceuticals、 Hikma Pharmaceuticals、 Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceutical Industries、 Viatris

*************************************************************

・調査・分析レポートの概要
慢性疲労症候群治療薬市場の定義
市場セグメント
世界の慢性疲労症候群治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の慢性疲労症候群治療薬市場規模
世界の慢性疲労症候群治療薬市場規模：2022年 VS 2029年
世界の慢性疲労症候群治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの慢性疲労症候群治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の慢性疲労症候群治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬
慢性疲労症候群治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：総合病院、専門医院
慢性疲労症候群治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別慢性疲労症候群治療薬市場規模 2022年と2029年
地域別慢性疲労症候群治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
AIM ImmunoTech、 Apotex、 Aurobindo Pharma、 Bionpharma、 Cadila Pharmaceuticals、 Hikma Pharmaceuticals、 Pfizer、 Sun Pharmaceutical Industries、 Teva Pharmaceutical Industries、 Viatris
...

Chronic fatigue syndrome, also known as Myalgic encephalomyelitis, is a chronic disease which lasts for six months and affects the central nervous system and the immune system. The disease leads to musculoskeletal disorders, impairment of long term memory, and disturbed sleep patterns. This results in substantial decline in social, occupational, educational, and personal activity among patients. There are no specific biomarkers or tests to diagnose chronic fatigue syndrome. Symptoms include sore throat, muscle pain, headache, and fatigue, which continues for months or years.
This report aims to provide a comprehensive presentation of the global market for Chronic Fatigue Syndrome Therapeutics Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Fatigue Syndrome Therapeutics Drug. This report contains market size and forecasts of Chronic Fatigue Syndrome Therapeutics Drug in global, including the following market information:
Global Chronic Fatigue Syndrome Therapeutics Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Chronic Fatigue Syndrome Therapeutics Drug market was valued at US$ 276.8 million in 2022 and is projected to reach US$ 374.2 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Chronic Fatigue Syndrome Treatment key players include Pfizer, Mylan, Teva, Depomed, etc. Global top four manufacturers hold a share over 35%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia-Pacific, both have a share over 45 percent.
In terms of product, Pain Relievers and NSAIDs is the largest segment, with a share over 60%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Fatigue Syndrome Therapeutics Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Fatigue Syndrome Therapeutics Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Chronic Fatigue Syndrome Therapeutics Drug Market Segment Percentages, by Type, 2022 (%)
Pain Relievers and NSAIDs
Antidepressant and Antipsychotic Drugs
Antimicrobial and Immunomodulatory Drugs
Global Chronic Fatigue Syndrome Therapeutics Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Chronic Fatigue Syndrome Therapeutics Drug Market Segment Percentages, by Application, 2022 (%)
General Hospitals
Specialty Clinics
Global Chronic Fatigue Syndrome Therapeutics Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Chronic Fatigue Syndrome Therapeutics Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Fatigue Syndrome Therapeutics Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chronic Fatigue Syndrome Therapeutics Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AIM ImmunoTech
Apotex
Aurobindo Pharma
Bionpharma
Cadila Pharmaceuticals
Hikma Pharmaceuticals
Pfizer
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Viatris
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Fatigue Syndrome Therapeutics Drug, market overview.
Chapter 2: Global Chronic Fatigue Syndrome Therapeutics Drug market size in revenue.
Chapter 3: Detailed analysis of Chronic Fatigue Syndrome Therapeutics Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Fatigue Syndrome Therapeutics Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Chronic Fatigue Syndrome Therapeutics Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Fatigue Syndrome Therapeutics Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Fatigue Syndrome Therapeutics Drug Overall Market Size
2.1 Global Chronic Fatigue Syndrome Therapeutics Drug Market Size: 2022 VS 2029
2.2 Global Chronic Fatigue Syndrome Therapeutics Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Fatigue Syndrome Therapeutics Drug Players in Global Market
3.2 Top Global Chronic Fatigue Syndrome Therapeutics Drug Companies Ranked by Revenue
3.3 Global Chronic Fatigue Syndrome Therapeutics Drug Revenue by Companies
3.4 Top 3 and Top 5 Chronic Fatigue Syndrome Therapeutics Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chronic Fatigue Syndrome Therapeutics Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Fatigue Syndrome Therapeutics Drug Players in Global Market
3.6.1 List of Global Tier 1 Chronic Fatigue Syndrome Therapeutics Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Fatigue Syndrome Therapeutics Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Chronic Fatigue Syndrome Therapeutics Drug Market Size Markets, 2022 & 2029
4.1.2 Pain Relievers and NSAIDs
4.1.3 Antidepressant and Antipsychotic Drugs
4.1.4 Antimicrobial and Immunomodulatory Drugs
4.2 By Type – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue & Forecasts
4.2.1 By Type – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2023
4.2.2 By Type – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2024-2029
4.2.3 By Type – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2022 & 2029
5.1.2 General Hospitals
5.1.3 Specialty Clinics
5.2 By Application – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue & Forecasts
5.2.1 By Application – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2023
5.2.2 By Application – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2024-2029
5.2.3 By Application – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2022 & 2029
6.2 By Region – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue & Forecasts
6.2.1 By Region – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2023
6.2.2 By Region – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2024-2029
6.2.3 By Region – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2029
6.3.2 US Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.3.3 Canada Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.3.4 Mexico Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2029
6.4.2 Germany Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.4.3 France Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.4.4 U.K. Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.4.5 Italy Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.4.6 Russia Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.4.7 Nordic Countries Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.4.8 Benelux Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2029
6.5.2 China Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.5.3 Japan Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.5.4 South Korea Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.5.5 Southeast Asia Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.5.6 India Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2029
6.6.2 Brazil Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.6.3 Argentina Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2029
6.7.2 Turkey Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.7.3 Israel Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
6.7.5 UAE Chronic Fatigue Syndrome Therapeutics Drug Market Size, 2018-2029
7 Chronic Fatigue Syndrome Therapeutics Drug Companies Profiles
7.1 AIM ImmunoTech
7.1.1 AIM ImmunoTech Company Summary
7.1.2 AIM ImmunoTech Business Overview
7.1.3 AIM ImmunoTech Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.1.4 AIM ImmunoTech Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.1.5 AIM ImmunoTech Key News & Latest Developments
7.2 Apotex
7.2.1 Apotex Company Summary
7.2.2 Apotex Business Overview
7.2.3 Apotex Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.2.4 Apotex Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.2.5 Apotex Key News & Latest Developments
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Company Summary
7.3.2 Aurobindo Pharma Business Overview
7.3.3 Aurobindo Pharma Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.3.4 Aurobindo Pharma Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.3.5 Aurobindo Pharma Key News & Latest Developments
7.4 Bionpharma
7.4.1 Bionpharma Company Summary
7.4.2 Bionpharma Business Overview
7.4.3 Bionpharma Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.4.4 Bionpharma Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.4.5 Bionpharma Key News & Latest Developments
7.5 Cadila Pharmaceuticals
7.5.1 Cadila Pharmaceuticals Company Summary
7.5.2 Cadila Pharmaceuticals Business Overview
7.5.3 Cadila Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.5.4 Cadila Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.5.5 Cadila Pharmaceuticals Key News & Latest Developments
7.6 Hikma Pharmaceuticals
7.6.1 Hikma Pharmaceuticals Company Summary
7.6.2 Hikma Pharmaceuticals Business Overview
7.6.3 Hikma Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.6.4 Hikma Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.6.5 Hikma Pharmaceuticals Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.7.4 Pfizer Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Sun Pharmaceutical Industries
7.8.1 Sun Pharmaceutical Industries Company Summary
7.8.2 Sun Pharmaceutical Industries Business Overview
7.8.3 Sun Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.8.4 Sun Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.8.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.10 Viatris
7.10.1 Viatris Company Summary
7.10.2 Viatris Business Overview
7.10.3 Viatris Chronic Fatigue Syndrome Therapeutics Drug Major Product Offerings
7.10.4 Viatris Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global Market (2018-2023)
7.10.5 Viatris Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Chronic Fatigue Syndrome Therapeutics Drug Market Opportunities & Trends in Global Market
Table 2. Chronic Fatigue Syndrome Therapeutics Drug Market Drivers in Global Market
Table 3. Chronic Fatigue Syndrome Therapeutics Drug Market Restraints in Global Market
Table 4. Key Players of Chronic Fatigue Syndrome Therapeutics Drug in Global Market
Table 5. Top Chronic Fatigue Syndrome Therapeutics Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chronic Fatigue Syndrome Therapeutics Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chronic Fatigue Syndrome Therapeutics Drug Product Type
Table 9. List of Global Tier 1 Chronic Fatigue Syndrome Therapeutics Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Fatigue Syndrome Therapeutics Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chronic Fatigue Syndrome Therapeutics Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2024-2029
Table 30. AIM ImmunoTech Company Summary
Table 31. AIM ImmunoTech Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 32. AIM ImmunoTech Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 33. AIM ImmunoTech Key News & Latest Developments
Table 34. Apotex Company Summary
Table 35. Apotex Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 36. Apotex Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Apotex Key News & Latest Developments
Table 38. Aurobindo Pharma Company Summary
Table 39. Aurobindo Pharma Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 40. Aurobindo Pharma Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Aurobindo Pharma Key News & Latest Developments
Table 42. Bionpharma Company Summary
Table 43. Bionpharma Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 44. Bionpharma Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Bionpharma Key News & Latest Developments
Table 46. Cadila Pharmaceuticals Company Summary
Table 47. Cadila Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 48. Cadila Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Cadila Pharmaceuticals Key News & Latest Developments
Table 50. Hikma Pharmaceuticals Company Summary
Table 51. Hikma Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 52. Hikma Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Hikma Pharmaceuticals Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 56. Pfizer Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Sun Pharmaceutical Industries Company Summary
Table 59. Sun Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 60. Sun Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Sun Pharmaceutical Industries Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Company Summary
Table 63. Teva Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 64. Teva Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Industries Key News & Latest Developments
Table 66. Viatris Company Summary
Table 67. Viatris Chronic Fatigue Syndrome Therapeutics Drug Product Offerings
Table 68. Viatris Chronic Fatigue Syndrome Therapeutics Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Viatris Key News & Latest Developments
List of Figures
Figure 1. Chronic Fatigue Syndrome Therapeutics Drug Segment by Type in 2022
Figure 2. Chronic Fatigue Syndrome Therapeutics Drug Segment by Application in 2022
Figure 3. Global Chronic Fatigue Syndrome Therapeutics Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Fatigue Syndrome Therapeutics Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Fatigue Syndrome Therapeutics Drug Revenue in 2022
Figure 8. By Type - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 16. US Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 20. Germany Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 28. China Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Chronic Fatigue Syndrome Therapeutics Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Chronic Fatigue Syndrome Therapeutics Drug Revenue, (US$, Mn), 2018-2029
Figure 41. AIM ImmunoTech Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Apotex Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Aurobindo Pharma Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bionpharma Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cadila Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hikma Pharmaceuticals Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sun Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Industries Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Viatris Chronic Fatigue Syndrome Therapeutics Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の慢性疲労症候群治療薬市場予測2023-2029：鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬] (コード：MMG23LY8416)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の慢性疲労症候群治療薬市場予測2023-2029：鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の精神薬＆神経薬市場2022年：抗うつ薬、抗不安薬、抗精神病薬、気分安定薬、覚醒剤、その他
  • 世界の精神療法薬市場2022年：抗うつ薬、抗精神病薬、抗不安薬、ADHD治療薬、その他
  • 世界のストレス管理薬市場予測2023-2029：抗うつ薬、非定型抗精神病薬、ベンゾジアゼピン系医薬品
  • 世界の疼痛管理用治療薬市場予測2023-2029：ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他
  • 世界の帯状疱疹後神経痛治療薬市場予測2023-2029：抗けいれん薬、抗うつ薬、オピオイド、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆